MYOS RENS Announces that Multiple Top-Tier Pet Insurance Companies Now Cover its Canine Nutrition Products
The following pet insurers are now covering MYOS Canine Muscle Formula:
Veterinary expenses account for
"I have been using Fortetropin in dogs for nearly 5 years. I find it particularly helpful in older dogs and canines with muscle atrophy," stated
A vast number of human and veterinary clinical studies have shown that gains in muscle mass and muscular strength are associated with improved longevity for both humans and animals. Additionally, specific veterinary clinical research has also shown that Labrador Retriever dogs with greater muscle mass had improved longevity.
"The decision by many veterinarians to recommend MYOS Canine to their patients is a testament to the efficacy of our product which is backed by high-caliber, published clinical research," stated
About Myos Canine Muscle Formula®
Myos Canine Muscle Formula (Regular and Veterinarian Strength) is an advanced veterinary health supplement to support muscle health in dogs, featuring Fortetropin® as the active ingredient. Fortetropin is made through a patented process that maintains the vital nutrients of fertilized egg yolks to help build more lean muscle and decrease muscle loss. For more information, please visit www.myospet.com.
About
Forward-Looking Statements
Any statements in this release that are not historical facts are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the ability to create new products through research and development, the successful results of strategic initiatives, the success of our products, including MYOS Canine Muscle Formula®, Yolked®, Physician Muscle Health Formula®, Qurr® and MYOS Enteral Nutrition Formula™, the success of our research and development, the results of the clinical evaluation of Fortetropin® and its effects, the ability to enter into new partnership opportunities and the success of our existing partnerships, the ability to generate revenue and cash flow from sales of our products, the ability to increase our revenue and gross profit margins, the ability to achieve a sustainable, profitable business, the effect of economic conditions, the ability to protect our intellectual property rights, competition from other providers and products, the continued listing of our securities on the
Investor Relations:
MYOS RENS Technology
Email: [email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/myos-rens-announces-that-multiple-top-tier-pet-insurance-companies-now-cover-its-canine-nutrition-products-301047834.html
SOURCE
Covered by SAGE Secures $6M Seed Funding From NFX, Acorns and Betterment Co-Founders, and Tectonic Capital to Build A Tech Powered Insurance Brokerage
Rep. Schakowsky: House Democratic Caucus Task Force on Aging & Families Outlines Blueprint for Protecting Older Americans Amid COVID-19
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News